Vasudha Sehgal

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 389 citations

Bd2 Bromodomain, Medicine, Natural Sciences +9

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber et al. · Cancer Discovery · 2024 · 77 citations

Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study

Lauren A. Byers, Dmitry Bentsion, Steven Gans et al. · Clinical Cancer Research · 2021 · 72 citations · Full text

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Elizabeth M. Swisher, Carol Aghajanian, David M. O’Malley et al. · Gynecologic Oncology · 2021 · 38 citations · Full text

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study

Benoît You, Vasudha Sehgal, Balakrishna Hosmane et al. · Journal of Clinical Oncology · 2022 · 35 citations · Full text